News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Vasospasm 2013 Conference Features Oral Presentation of Edge Therapeutics’ EG-1962


7/12/2013 8:07:04 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Edge Therapeutics today announced that researchers from Heinrich Heine University in Düsseldorf, Germany presented positive results of the first clinical application of EG-1962 (nimodipine microparticles), a sustained release injectable formulation of nimodipine for improvement of outcome and prevention of delayed cerebral ischemia (DCI) after aneurysmal subarachnoid hemorrhage (SAH).

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES